等待开盘 04-01 09:30:00 美东时间
+0.750
+7.65%
Omeros (NASDAQ:OMER) reported quarterly earnings of $3.14 per share which beat the analyst consensus estimate of $(0.57) by 650.88 percent. This is a 598.41 percent increase over losses of $(0.63) per share from the same
今天 04:06
Companies Reporting Before The Bell • Bitfarms (NASDAQ:BITF) is projected to re...
03-31 19:11
Omeros (OMER) is scheduled to announce Q4 earnings results on Monday, March 30th, after market close. The consensus EPS Estimate is $0.36 (+166.7% Y/Y) and the consensus Revenue Estimate is $0M Over t...
03-31 05:35
Omeros updates its financial calendar; management hosts a conference call and webcast for FY2025 results Omeros will release financial results for the fourth quarter and year ended Dec. 31, 2025 on March 31, 2026 after market close. A conference call and webcast is scheduled for March 31, 2026 at 4:
03-26 20:45
Omeros to host EBMT industry session on TA-TMA treatment advances Omeros will host an industry session at the 52nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) on March 22, 2026, from 2:30pm to 4pm CET in Madrid. The session is titled “Advances in TA-TMA Treatme
03-21 15:23
Omeros Corporation (NASDAQ: OMER) today announced the successful completion of its initial study in nonhuman primates evaluating the efficacy and safety of its OncotoX-AML cancer therapeutic platform. Omeros' OncotoX-AML
02-17 21:46
Omeros Reports Successful Primate Study of OncotoX-AML for Leukemia Treatment Omeros Corporation announced the successful completion of an initial nonhuman primate study evaluating its OncotoX-AML therapeutic platform for acute myeloid leukemia (AML). The study demonstrated a marked, selective, and
02-17 21:45
This whale alert can help traders discover the next big trading opportunities. ...
02-05 01:35
Shares of Omeros Corporation (OMER) gained on Tuesday after the company announced first commercial shipments of Yartemlea, its recently approved therapy for hematopoietic stem cell transplant-associat...
01-28 01:38